ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)
$11.8 0.15 (1.2876%)
Analysed ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) News Sources
Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)
23-06-2026
yahoo.com
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
22-07-2026
yahoo.com
Zevra Therapeutics Receives EMA Negative Opinion on Arimoclomol Marketing Application
24-07-2026
advfn.com
ZVRA Stock Sinks 23% On EU Setback — Analyst Says Risk Is ‘A Headwind, But Not Insurmountable’
24-07-2026
stocktwits.com
Zevra Reports Second Quarter 2026 Financial Results and Corporate Update
05-08-2026
yahoo.com
Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates
06-08-2026
yahoo.com
Zevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights: Revenue Surges 53% as ...
06-08-2026
yahoo.com
Zevra Therapeutics Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
What Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review?
07-08-2026
yahoo.com
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
21-08-2026
yahoo.com
What is the current price of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The current price of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is $11.8.
ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) since the previous trading day is $0.15.
ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) since the previous trading day is 1.2876%.
What is the most recent average sentiment score for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The most recent average sentiment score for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The most recent sentiment for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is .
SEC-8K** Filing Available For ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.